
Please try another search
By Michael Elkins
An April 6th accident involving a truck fitted with TuSimple (NASDAQ:TSP) autonomous driving technology has garnered attention from safety regulators following a June report that contradicts the company’s claim that the accident was caused by human error.
An internal TuSimple report, viewed by The Wall Street Journal, said the semi-tractor truck abruptly veered left because a person in the cab hadn’t properly rebooted the autonomous driving system before engaging it, causing it to execute an outdated command. The internal account reported that the left-turn command was 2 1/2 minutes old and should have been erased from the system but wasn’t.
Researchers at Carnegie Mellon University said it was the autonomous-driving system that turned the wheel and that blaming the entire accident on human error is misleading.
“This information shows that the testing they are doing on public roads is highly unsafe,” said Phil Koopman, an associate professor at Carnegie Mellon who has contributed to international safety standards for autonomous vehicles, referring to the company’s disclosures.
TuSimple said that after the accident, it modified its autonomous-driving system so that a human can’t engage it unless the computer system is fully functional. A move that was described by a former employee as “long overdue.”
The TuSimple spokesman, in response, said the April accident was the only one in which a company truck was responsible for an accident.
TSP is down 8.75% in mid-day trading.
(Reuters) - Russia has failed to gain ground in cyberspace against Ukraine almost six months after its invasion of the country, the head of Britain's GCHQ intelligence service...
By David Shepardson WASHINGTON (Reuters) -General Motors Co and LG Energy Solution are considering a site in Indiana for a fourth U.S. battery cell manufacturing plant, a...
By Mrinalika Roy (Reuters) -Bluebird bio slumped nearly 15% on Thursday as investors fretted over sales potential of its newly approved ultra-rare blood disorder gene therapy that...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.